Cargando…

A brain-penetrant triazolopyrimidine enhances microtubule-stability, reduces axonal dysfunction and decreases tau pathology in a mouse tauopathy model

BACKGROUND: Alzheimer’s disease (AD) and related tauopathies are neurodegenerative diseases that are characterized by the presence of insoluble inclusions of the protein tau within brain neurons and often glia. Tau is normally found associated with axonal microtubules (MTs) in the brain, and in tauo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Bin, Yao, Yuemang, Cornec, Anne-Sophie, Oukoloff, Killian, James, Michael J., Koivula, Pyry, Trojanowski, John Q., Smith, Amos B., Lee, Virginia M.-Y., Ballatore, Carlo, Brunden, Kurt R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223064/ https://www.ncbi.nlm.nih.gov/pubmed/30404654 http://dx.doi.org/10.1186/s13024-018-0291-3

Ejemplares similares

Evaluation of the brain-penetrant microtubule-stabilizing agent, dictyostatin, in the PS19 tau transgenic mouse model of tauopathy
por: Makani, Vishruti, et al.
Publicado: (2016)

Brain-Penetrant, Orally Bioavailable Microtubule-Stabilizing Small Molecules Are Potential Candidate Therapeutics for Alzheimer’s Disease and Related Tauopathies
por: Lou, Kevin, et al.
Publicado: (2014)

Multitargeted Imidazoles: Potential Therapeutic Leads for Alzheimer’s and Other Neurodegenerative Diseases
por: Cornec, Anne-Sophie, et al.
Publicado: (2017)

Microtubule-Stabilizing 1,2,4-Triazolo[1,5-a]pyrimidines as Candidate Therapeutics for Neurodegenerative Disease: Matched Molecular Pair Analyses and Computational Studies Reveal New Structure–Activity Insights
por: Alle, Thibault, et al.
Publicado: (2022)

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies
por: Trojanowski, John Q
Publicado: (2013)

Effects of microglial depletion and TREM2 deficiency on Aβ plaque burden and neuritic plaque tau pathology in 5XFAD mice
por: Delizannis, Argyro Thalia, et al.
Publicado: (2021)

Passive Immunization with Phospho-Tau Antibodies Reduces Tau Pathology and Functional Deficits in Two Distinct Mouse Tauopathy Models
por: Sankaranarayanan, Sethu, et al.
Publicado: (2015)

CSF tau microtubule-binding region identifies pathological changes in primary tauopathies
por: Horie, Kanta, et al.
Publicado: (2022)

New Trifluoromethyl Triazolopyrimidines as Anti-Plasmodiumfalciparum Agents
por: Boechat, Núbia, et al.
Publicado: (2012)

The synthesis and evaluation of triazolopyrimidines as anti-tubercular agents
por: Zuniga, Edison S., et al.
Publicado: (2017)

Triazolopyrimidines Target Aerobic Respiration in Mycobacterium tuberculosis
por: Shelton, Catherine, et al.
Publicado: (2022)

Transcellular Spreading of Tau in Tauopathies
por: Demaegd, Koen, et al.
Publicado: (2018)

Conformation-selective tau monoclonal antibodies inhibit tau pathology in primary neurons and a mouse model of Alzheimer’s disease
por: Gibbons, Garrett S., et al.
Publicado: (2020)

Are Tau Aggregates Toxic or Protective in Tauopathies?
por: Cowan, Catherine M., et al.
Publicado: (2013)

NMR Studies of Tau Protein in Tauopathies
por: Kitoka, Kristine, et al.
Publicado: (2021)

P301S Mutant Human Tau Transgenic Mice Manifest Early Symptoms of Human Tauopathies with Dementia and Altered Sensorimotor Gating
por: Takeuchi, Hiroki, et al.
Publicado: (2011)

Tau mediates microtubule bundle architectures mimicking fascicles of microtubules found in the axon initial segment
por: Chung, Peter J., et al.
Publicado: (2016)

Design, Synthesis, and Evaluation of Anticonvulsant Activities of New Triazolopyrimidine Derivatives
por: Song, Mingxia, et al.
Publicado: (2022)

Tau deposition patterns are associated with functional connectivity in primary tauopathies
por: Franzmeier, Nicolai, et al.
Publicado: (2022)

Tau exon 10 alternative splicing and tauopathies
por: Liu, Fei, et al.
Publicado: (2008)

Glial Tau Pathology in Tauopathies: Functional Consequences
por: Kahlson, Martha A., et al.
Publicado: (2016)

Tau Spreading Mechanisms; Implications for Dysfunctional Tauopathies
por: Fuster-Matanzo, Almudena, et al.
Publicado: (2018)

The Role of Microglia in the Spread of Tau: Relevance for Tauopathies
por: Perea, Juan R., et al.
Publicado: (2018)

Involvement of Oligodendrocytes in Tau Seeding and Spreading in Tauopathies
por: Ferrer, Isidro, et al.
Publicado: (2019)

Targeting tauopathy with engineered tau-degrading intrabodies
por: Gallardo, Gilbert, et al.
Publicado: (2019)

Phosphorylated Tau in Alzheimer’s Disease and Other Tauopathies
por: Rawat, Priyanka, et al.
Publicado: (2022)

Inflammatory Eicosanoids Increase Amyloid Precursor Protein Expression via Activation of Multiple Neuronal Receptors
por: Herbst-Robinson, Katie J., et al.
Publicado: (2015)

Axonal Degeneration in Tauopathies: Disease Relevance and Underlying Mechanisms
por: Kneynsberg, Andrew, et al.
Publicado: (2017)

Region-specific dendritic simplification induced by Aβ, mediated by tau via dysregulation of microtubule dynamics: a mechanistic distinct event from other neurodegenerative processes
por: Golovyashkina, Nataliya, et al.
Publicado: (2015)

Role of tau in the spatial organization of axonal microtubules: keeping parallel microtubules evenly distributed despite macromolecular crowding
por: Méphon-Gaspard, Alix, et al.
Publicado: (2016)

Identification of small molecules and related targets that modulate tau pathology in a seeded primary neuron model
por: Gibbons, Garrett S., et al.
Publicado: (2023)

Brain inflammation and oxidative stress in a transgenic mouse model of Alzheimer-like brain amyloidosis
por: Yao, Yuemang, et al.
Publicado: (2004)

Transmission of tauopathy strains is independent of their isoform composition
por: He, Zhuohao, et al.
Publicado: (2020)

SHORT TELOMERES ASSOCIATE WITH HYPERPHOSPHORYLATED TAU BURDEN IN PRIMARY AGE-RELATED TAUOPATHY
por: McMillan, Corey, et al.
Publicado: (2022)

Cytotoxic Activity of Organotin(IV) Derivatives with Triazolopyrimidine Containing Exocyclic Oxygen Atoms
por: Attanzio, Alessandro, et al.
Publicado: (2020)

Platinum(II) Complexes with Bulky Disubstitute Triazolopyrimidines as Promising Materials for Anticancer Agents
por: Łakomska, Iwona, et al.
Publicado: (2020)

PET Imaging of Tau Pathology in Alzheimer’s Disease and Tauopathies
por: James, Olga G., et al.
Publicado: (2015)

Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies?
por: Laurent, Cyril, et al.
Publicado: (2018)

VPS35 regulates tau phosphorylation and neuropathology in tauopathy
por: Vagnozzi, Alana N., et al.
Publicado: (2021)

Colocalization of BRCA1 with Tau Aggregates in Human Tauopathies
por: Kurihara, Masanori, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_j7dapncvkavmtgl6aqu0q4tq1r